View Item 

Show simple item record

Effect of Atrial Fibrillation Duration on Probability of Immediate Recurrence after Transthoracic Cardioversion
dc.contributor.authorOral, Hakanen_US
dc.contributor.authorOzaydin, Mehmeten_US
dc.contributor.authorSticherling, Christianen_US
dc.contributor.authorTada, Hiroshien_US
dc.contributor.authorScharf, Christophen_US
dc.contributor.authorChugh, Amanen_US
dc.contributor.authorLai, Steve W. K.en_US
dc.contributor.authorPelosi, Frank Jr.en_US
dc.contributor.authorKnight, Bradley P.en_US
dc.contributor.authorStrickberger, S. Adamen_US
dc.contributor.authorMorady, Freden_US
dc.date.accessioned2010-06-01T19:31:00Z
dc.date.available2010-06-01T19:31:00Z
dc.date.issued2003-02en_US
dc.identifier.citationORAL, HAKAN; OZAYDIN, MEHMET; STICHERLING, CHRISTIAN; TADA, HIROSHI; SCHARF, CHRISTOPH; CHUGH, AMAN; LAI, STEVE W.K.; PELOSI, FRANK; KNIGHT, BRADLEY P.; STRICKBERGER, S. ADAM; MORADY, FRED (2003). "Effect of Atrial Fibrillation Duration on Probability of Immediate Recurrence after Transthoracic Cardioversion." Journal of Cardiovascular Electrophysiology 14(2): 182-185. <http://hdl.handle.net/2027.42/72654>en_US
dc.identifier.issn1045-3873en_US
dc.identifier.issn1540-8167en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/72654
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12693502&dopt=citationen_US
dc.format.extent74792 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Science Incen_US
dc.rights2003 by Blackwell Futura Publishing, Inc.en_US
dc.subject.otherAtrial Fibrillationen_US
dc.subject.otherCardioversionen_US
dc.subject.otherImmediate Recurrence of Atrial Fibrillationen_US
dc.subject.otherPulmonary Veinen_US
dc.titleEffect of Atrial Fibrillation Duration on Probability of Immediate Recurrence after Transthoracic Cardioversionen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelInternal Medicine and Specialtiesen_US
dc.subject.hlbsecondlevelPhysiologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumFrom the Division of Cardiology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USAen_US
dc.identifier.pmid12693502en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/72654/1/j.1540-8167.2003.02415.x.pdf
dc.identifier.doi10.1046/j.1540-8167.2003.02415.xen_US
dc.identifier.sourceJournal of Cardiovascular Electrophysiologyen_US
dc.identifier.citedreferenceDaoud EG, Hummel JD, Augostini R, Williams S, Kalbfleisch SJ: Effect of verapamil on immediate recurrence of atrial fibrillation. J Cardiovasc Electrophysiol 2000; 11: 1231 - 1237.en_US
dc.identifier.citedreferenceTieleman RG, Van Gelder IC, Crijns HJ, De Kam PJ, Van Den Berg MP, Haaksma J, Van Der Woude HJ, Allessie MA: Early recurrences of atrial fibrillation after electrical cardioversion: A result of fibrillation-induced electrical remodeling of the atria? J Am Coll Cardiol 1998; 31: 167 - 173.en_US
dc.identifier.citedreferenceVan Noord T, Van Gelder IC, Schoonderwoerd BA, Crijns HJ: Immediate reinitiation of atrial fibrillation after electrical cardioversion predicts subsequent pharmacologic and electrical conversion to sinus rhythm and amiodarone. Am J Cardiol 2000; 86: 1384 - 1385.en_US
dc.identifier.citedreferenceCrijns HJ, van Noord T, van Gelder IC: Recurrence of atrial fibrillation and the need for new definitions. Eur Heart J 2001; 22: 1769 - 1771.en_US
dc.identifier.citedreferenceWellens HJ, Lau CP, Luderitz B, Akhtar M, Waldo AL, Camm AJ, Timmermans C, Tse HF, Jung W, Jordaens L, Ayers G: Atrioverter: An implantable device for the treatment of atrial fibrillation. Circulation 1998; 98: 1651 - 1656.en_US
dc.identifier.citedreferenceLiebold A, Wahba A, Birnbaum DE: Low-energy cardioversion with epicardial wire electrodes: New treatment of atrial fibrillation after open heart surgery. Circulation 1998; 98: 883 - 886.en_US
dc.identifier.citedreferenceSchwartzman D, Musley SK, Swerdlow C, Hoyt RH, Warman EN: Early recurrence of atrial fibrillation after ambulatory shock conversion. J Am Coll Cardiol 2002; 40: 93 - 99.en_US
dc.identifier.citedreferenceDuytschaever M, Danse P, Allessie M: Supervulnerable phase immediately after termination of atrial fibrillation. J Cardiovasc Electrophysiol 2002; 13: 267 - 275.en_US
dc.identifier.citedreferenceOral H, Knight BP, Ozaydin M, Chugh A, Hassan S, Scharf C, Lai SW, Greenstein R, Han J, Pelosi F, Strickberger SA, Morady F: Segmental ostial ablation to isolate the pulmonary veins during atrial fibrillation: Feasibility and mechanistic insights. Circulation 2002; 106: 1256 - 1262.en_US
dc.identifier.citedreferenceChen SA, Hsieh MH, Tai CT, Tsai CF, Prakash VS, Yu WC, Hsu TL, Ding YA, Chang MS: Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: Electrophysiological characteristics, pharmacological responses, and effects of radiofrequency ablation. Circulation 1999; 100: 1879 - 1886.en_US
dc.identifier.citedreferenceOral H, Ozaydin M, Tada H, Chugh A, Scharf C, Hassan S, Lai S, Greenstein R, Pelosi F Jr, Knight BP, Strickberger SA, Morady F: Mechanistic significance of intermittent pulmonary vein tachycardia in patients with atrial fibrillation. J Cardiovasc Electrophysiol 2002; 13: 645 - 650.en_US
dc.identifier.citedreferenceOral H, Knight BP, Tada H, Morady F: Tachycardia and bradycardia coexisting in the same pulmonary vein. J Cardiovasc Electrophysiol 2002; 13: 186 - 188.en_US
dc.identifier.citedreferenceDittrich HC, Erickson JS, Schneiderman T, Blacky AR, Savides T, Nicod PH: Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. Am J Cardiol 1989; 63: 193 - 197.en_US
dc.identifier.citedreferenceVan Gelder IC, Crijns HJ, Van Gilst WH, Verwer R, Lie KI: Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter. Am J Cardiol 1991; 68: 41 - 46.en_US
dc.identifier.citedreferenceVan Gelder IC, Crijns HJ, Tieleman RG, Brugemann J, De Kam PJ, Gosselink AT, Verheugt FW, Lie KI: Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. Arch Intern Med 1996; 156: 2585 - 2592.en_US
dc.identifier.citedreferenceLevy S, Ricard P, Lau CP, Lok NS, Camm AJ, Murgatroyd FD, Jordaens LJ, Kappenberger LJ, Brugada P, Ripley KL: Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation. J Am Coll Cardiol 1997; 29: 750 - 755.en_US
dc.identifier.citedreferenceWijffels MC, Kirchhof CJ, Dorland R, Allessie MA: Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995; 92: 1954 - 1968.en_US
dc.identifier.citedreferenceKim BS, Kim YH, Hwang GS, Pak HN, Lee SC, Shim WJ, Oh DJ, Ro YM: Action potential duration restitution kinetics in human atrial fibrillation. J Am Coll Cardiol 2002; 39: 1329 - 1336.en_US
dc.identifier.citedreferenceLau CP, Tse HF, Ayers GM: Defibrillation-guided radiofrequency ablation of atrial fibrillation secondary to an atrial focus. J Am Coll Cardiol 1999; 33: 1217 - 1226.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1540-8167.2003.02415.x.pdf
Size:
73.03KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.